Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director, Project Management. This newly created key leadership position will elevate internal collaboration for the organization as it develops and commercializes first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Seasoned executives with CVOT project management leadership are encouraged to contact Bonnie Stofer for confidential consideration at bonnie@chasegroup.com.
Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role
Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director, Project Management. This newly created key leadership position will elevate internal collaboration for the organization as it develops and commercializes first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Seasoned executives with CVOT project management leadership are encouraged to contact Bonnie Stofer for confidential consideration at bonnie@chasegroup.com.- Categories: Life Sciences, Pharmaceutical, Research & Development
Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs
The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global & US Medical Affairs for Eli Lilly. The successful candidate…
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership with Marinus in building their leadership team with the recent placement of the Vice President of Clinical…-
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice… 
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with…
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board…